EssilorLuxottica Société anonyme (ESLOY)
OTCMKTS
· Delayed Price · Currency is USD
132.71
+1.13 (0.86%)
Jan 23, 2025, 4:00 PM EST
ESLOY Revenue
EssilorLuxottica Société anonyme had revenue of 13.29B EUR in the half year ending June 30, 2024, with 10.81% growth. This brings the company's revenue in the last twelve months to 25.83B, up 1.91% year-over-year. In the year 2023, EssilorLuxottica Société anonyme had annual revenue of 25.40B with 3.68% growth.
Revenue (ttm)
25.83B EUR
Revenue Growth
+1.91%
P/S Ratio
n/a
Revenue / Employee
170.76K EUR
Employees
151,292
Market Cap
120.76B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
| Dec 31, 2019 | 17.39B | 6.56B | 60.53% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
EssilorLuxottica Société anonyme News
- 2 days ago - Meta’s next smart glasses may be with Oakley - The Verge
- 6 days ago - Billionaire clans jostle for power in Italy’s reshaped banking sector - Fortune
- 21 days ago - EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France - GlobeNewsWire
- 4 weeks ago - Meta Plans Display-Equipped Ray-Ban Glasses By 2025: FT - Benzinga
- 5 weeks ago - EssilorLuxottica and Prada extend eyewear licensing agreement - Reuters
- 5 weeks ago - EssilorLuxottica: Prada Group and EssilorLuxottica announce ten-years licensing renewal - GlobeNewsWire
- 5 weeks ago - EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space - GlobeNewsWire
- 6 weeks ago - EssilorLuxottica: EssilorLuxottica's greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi) - GlobeNewsWire